Loading provider…
Loading provider…
Nephrology Physician in Allentown, PA
NPI: 1104802891Primary Practice Location
LEHIGH VALLEY HOSPITAL
1627 Chew St, Allentown, PA
Primary Employer
Kidney Care Specialists LLC
kidneycareohio.com
HQ Phone
Get DO Nelson's Phone Numberphone_androidMobile
Get DO Nelson's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNJ State Medical License
PA State Medical License

NJ State License
1980 - 2027

PA State License
1980 - 2026

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Nephrology
Temple University Hospital
Fellowship • Nephrology
1983 - 1985
Residency • Internal Medicine
1980 - 1983
Pcom
Medical School
Until 1979
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 145 | 278 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 108 | 214 |
| 3 | 90935Hemodialysis procedure with one physician evaluation | 61 | 106 |
| 4 | 99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 49 | 50 |
| 5 | 90960Dialysis services (4 or more physician visits per month), patient 20 years of age and older | 48 | 217 |
Authors: Rajiv Agarwal
Journal: Am J Kidney Dis
Authors: Anne Huml, Clive Rosendorff, Mario Henriquez, Barry Davis, Jan Basile
Journal: Clin Nephrol
Pharmacological effects of ex vivo mesenchymal stem cell immunotherapy in patients with acute kidney injury and underlying systemic inflammation.
Authors: Kausik Umanath, Mohamed Atta
Publication Date: 2021-02-04
Lead Sponsor: Chinook Therapeutics, Inc.
Intervention / Treatment: DRUG: Placebo, DRUG: Atrasentan
Lead Sponsor: Mineralys Therapeutics Inc.
Intervention / Treatment: DRUG: Placebo, DRUG: lorundrostat Dose 2, DRUG: lorundrostat Dose 1
Lead Sponsor: Palladio Biosciences
Collaborators: Centessa Pharmaceuticals plc
Intervention / Treatment: DRUG: Lixivaptan